BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

613 related articles for article (PubMed ID: 29700172)

  • 1. The early expansion of anergic NKG2A
    Roberto A; Di Vito C; Zaghi E; Mazza EMC; Capucetti A; Calvi M; Tentorio P; Zanon V; Sarina B; Mariotti J; Bramanti S; Tenedini E; Tagliafico E; Bicciato S; Santoro A; Roederer M; Marcenaro E; Castagna L; Lugli E; Mavilio D
    Haematologica; 2018 Aug; 103(8):1390-1402. PubMed ID: 29700172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Cytomegalovirus Reactivation and Expansion of CD56
    Jang JE; Hwang DY; Chung H; Kim SJ; Eom JI; Jeung HK; Song J; Kim JS; Cheong JW; Min YH
    Biol Blood Marrow Transplant; 2019 Oct; 25(10):2070-2078. PubMed ID: 31212079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56
    Euchner J; Sprissler J; Cathomen T; Fürst D; Schrezenmeier H; Debatin KM; Schwarz K; Felgentreff K
    Front Immunol; 2021; 12():640672. PubMed ID: 34017328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A New Hope for CD56
    Forconi CS; Oduor CI; Oluoch PO; Ong'echa JM; Münz C; Bailey JA; Moormann AM
    Front Cell Infect Microbiol; 2020; 10():162. PubMed ID: 32373555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An unusual CD56(bright) CD16(low) NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantation.
    Dulphy N; Haas P; Busson M; Belhadj S; Peffault de Latour R; Robin M; Carmagnat M; Loiseau P; Tamouza R; Scieux C; Rabian C; Di Santo JP; Charron D; Janin A; Socié G; Toubert A
    J Immunol; 2008 Aug; 181(3):2227-37. PubMed ID: 18641363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expressions of natural cytotoxicity receptors and NKG2D on decidual natural killer cells in patients having spontaneous abortions.
    Zhang Y; Zhao A; Wang X; Shi G; Jin H; Lin Q
    Fertil Steril; 2008 Nov; 90(5):1931-7. PubMed ID: 18023431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of KIR
    Di Vito C; Coianiz N; Calvi M; Terzoli S; Zaghi E; Puccio S; Frigo A; Mariotti J; De Philippis C; Mannina D; Sarina B; Mineri R; Le-Trilling VTK; Trilling M; Castagna L; Bramanti S; Santoro A; Mavilio D
    Front Immunol; 2023; 14():1266051. PubMed ID: 38268918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD56negCD16⁺ NK cells are activated mature NK cells with impaired effector function during HIV-1 infection.
    Milush JM; López-Vergès S; York VA; Deeks SG; Martin JN; Hecht FM; Lanier LL; Nixon DF
    Retrovirology; 2013 Dec; 10():158. PubMed ID: 24351015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Peripheral NKG2A-NKG2D+CD3-CD16+CD56dim NK Cell Subset Was Positively Correlated with Antiphospholipid Antibodies in Patients of Obstetric Antiphospholipid Syndrome.
    Zhang Y; Zhao Y; Si W; Yang B; Lin M; Zheng J; Cui L
    Immunol Invest; 2022 Feb; 51(2):425-437. PubMed ID: 33103514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct natural killer cells in HIV-exposed seronegative subjects with effector cytotoxic CD56(dim) and CD56(bright) cells and memory-like CD57⁺NKG2C⁺CD56(dim) cells.
    Lima JF; Oliveira LM; Pereira NZ; Mitsunari GE; Duarte AJ; Sato MN
    J Acquir Immune Defic Syndr; 2014 Dec; 67(5):463-71. PubMed ID: 25230289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NK cell maturation to CD56(dim) subset associated with high levels of NCRs overrides the inhibitory effect of NKG2A and recovers impaired NK cell cytolytic potential after allogeneic hematopoietic stem cell transplantation.
    Ghasemzadeh M; Hosseini E; Schwarer AP; Pourfathollah AA
    Leuk Res; 2016 Apr; 43():58-65. PubMed ID: 26856773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD56-enriched donor cell infusion after post-transplantation cyclophosphamide for haploidentical transplantation of advanced myeloid malignancies is associated with prompt reconstitution of mature natural killer cells and regulatory T cells with reduced incidence of acute graft versus host disease: A pilot study.
    Jaiswal SR; Zaman S; Nedunchezhian M; Chakrabarti A; Bhakuni P; Ahmed M; Sharma K; Rawat S; O'donnell P; Chakrabarti S
    Cytotherapy; 2017 Apr; 19(4):531-542. PubMed ID: 28131632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Terminal Differentiation of CD56(dim)CD16(+) Natural Killer Cells Is Associated with Increase in Natural Killer Cell Frequencies After Antiretroviral Treatment in HIV-1 Infection.
    Ahmad F; Tufa DM; Mishra N; Jacobs R; Schmidt RE
    AIDS Res Hum Retroviruses; 2015 Dec; 31(12):1206-12. PubMed ID: 26352913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haploidentical Stem Cell Transplantation in Children With Hematological Malignancies Using αβ
    Diaz MA; Zubicaray J; Molina B; Abad L; Castillo A; Sebastian E; Galvez E; Ruiz J; Vicario JL; Ramirez M; Sevilla J; González-Vicent M
    Front Immunol; 2019; 10():2504. PubMed ID: 31736949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased number of CD16(+)CD56(dim) NK cells in peripheral blood mononuclear cells after allogeneic cord blood transplantation.
    Tanaka J; Sugita J; Asanuma S; Arita K; Shono Y; Kikutchi M; Shiratori S; Wakasa K; Yasumoto A; Shigematu A; Kondo T; Kobayashi T; Asaka M; Imamura M
    Hum Immunol; 2009 Sep; 70(9):701-5. PubMed ID: 19524005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expansion of CD56-negative, CD16-positive, KIR-expressing natural killer cells after T cell-depleted haploidentical hematopoietic stem cell transplantation.
    De Angelis C; Mancusi A; Ruggeri L; Capanni M; Urbani E; Velardi A; Stern M
    Acta Haematol; 2011; 126(1):13-20. PubMed ID: 21411985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective depletion of CD56(dim) NK cell subsets and maintenance of CD56(bright) NK cells in treatment-naive HIV-1-seropositive individuals.
    Tarazona R; Casado JG; Delarosa O; Torre-Cisneros J; Villanueva JL; Sanchez B; Galiani MD; Gonzalez R; Solana R; Peña J
    J Clin Immunol; 2002 May; 22(3):176-83. PubMed ID: 12078859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased natural killer cell subsets with inhibitory cytokines and inhibitory surface receptors in patients with recurrent miscarriage and decreased or normal subsets in kidney transplant recipients late post-transplant.
    Zhu L; Aly M; Wang H; Karakizlis H; Weimer R; Morath C; Kuon RJ; Toth B; Ekpoom N; Opelz G; Daniel V
    Clin Exp Immunol; 2018 Aug; 193(2):241-254. PubMed ID: 29679490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of memory-like natural killer cells in human cytomegalovirus-infected children undergoing αβ+T and B cell-depleted hematopoietic stem cell transplantation for hematological malignancies.
    Muccio L; Bertaina A; Falco M; Pende D; Meazza R; Lopez-Botet M; Moretta L; Locatelli F; Moretta A; Della Chiesa M
    Haematologica; 2016 Mar; 101(3):371-81. PubMed ID: 26659918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation.
    Vago L; Forno B; Sormani MP; Crocchiolo R; Zino E; Di Terlizzi S; Lupo Stanghellini MT; Mazzi B; Perna SK; Bondanza A; Middleton D; Palini A; Bernardi M; Bacchetta R; Peccatori J; Rossini S; Roncarolo MG; Bordignon C; Bonini C; Ciceri F; Fleischhauer K
    Blood; 2008 Oct; 112(8):3488-99. PubMed ID: 18645039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.